StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Olopatadine Hydrochloride

HCID 5282402
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
140462-76-6
Standard-SMILES
CN(C)CC/C=C1/c2ccccc2COc2ccc(CC(=O)O)cc21.Cl
InChIKey
HVRLZEKDTUEKQH-NOILCQHBSA-N
Summenformel
C21H24ClNO3
Durchschnittliche Molmasse
373,9 g/mol
Monoisotopische Masse
373,14447131

Überblick

Olopatadine hydrochloride is a dibenzooxazepine.

Namen und Bezeichner

Bevorzugter Name
Olopatadine Hydrochloride
IUPAC
2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid;hydrochloride
Englischer Name
Olopatadine hydrochloride
Summenformel
C21H24ClNO3
Molmasse
373.88

Namen und Synonyme

OLOPATADINE HYDROCHLORIDE140462-76-6OLOPATADINE HClPatadayAllelockPatanasePazeoALO4943AKW4679DTXSID0046486KW-4679ALO-4943A
Weitere Namen anzeigen
Olopatadin HCLOLAPATADINE HCLPatanolOlopatadine HydrochlordeDibenz[b,e]oxepin-2-acetic acid, 11-[3-(dimethylamino)propylidene]-6,11-dihydro-, hydrochloride (1:1), (11Z)-OpatanolAL-4943AOLOPATDINEHYDROCHLORIDE
Olopatadine (as hydrochloride)2XG66W44KFDTXCID8026486Dibenz(b,e)oxepin-2-acetic acid, 11-(3-(dimethylamino)propylidene)-6,11-dihydro-, hydrochloride, (Z)-RYALTRIS COMPONENT OLOPATADINE HYDROCHLORIDERetaine AllergyOnce Daily ReliefRefChem:56800

Datenbank-Bezeichner

CAS
140462-76-6
PubChem CID
5282402
DTXSID
DTXSID0046486
ChEMBL
CHEMBL1719
ChEBI
CHEBI:31933
UNII
2XG66W44KF
EC Number
604-185-4

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
49,8 Ų
H-Brücken-Donoren
2
H-Brücken-Akzeptoren
4
Frei drehbare Bindungen
5
Schwere Atome
26
Formalladung
0
Komplexität
488

Experimentelle und physikochemische Eigenschaften

Human Drugs · 3 Einträge

FDA approved drugs -> Active ingredient

EMA approved medicines: Human medicine

FDA approved drugs -> Active ingredient

Physikochemische Eigenschaften

Schmelzpunkt
242 · 242-245C
storage temp.
Inert atmosphere,Room Temperature
Löslichkeit
2 O: · H2O: ≥20mg/mL
Aggregatzustand
solid
Farbe
White to Light yellow
Wasserlöslichkeit
2 O: · H2O: ≥20mg/mL
Merck
14 · 14,6840
BCS Class
3 · 3(CLogP), 1 (LogP)
InChI
InChI=1S/C21H23NO3.ClH/c1-22(2)11-5-8-18-17-7-4-3-6-16(17)14-25-20-10-9-15(12-19(18)20)13-21(23)24;/h3-4,6-10,12H,5,11,13-14H2,1-2H3,(H,23,24);1H/b18-8-;
InChIKey
HVRLZEKDTUEKQH-NOILCQHBSA-N
SMILES
C(=C1/C2=CC=CC=C2COC2C=CC(CC(=O)O)=CC/1=2)\CCN(C)C.Cl
CAS Datenbank
140462 · 140462-76-6(CAS DataBase Reference)

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 5 Einträge

This chemical does not meet GHS hazard criteria for 4.3% (2 of 47) of reports.

Danger

H301 (87.2%): Toxic if swallowed [Danger Acute toxicity, oral]

P264, P270, P273, P301+P316, P321, P330, P391, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 47 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Hazard Classes and CategoriesAcute Tox. 3 (87.2%)

Toxikologische Informationen

Exposure RoutesOphthalmic use of olopatadine usually does not produce measurable plasma concentrations.
Toxicity Summary · 1 Eintrag

Olopatadine is a selective histamine H1 antagonist that binds to the histamine H1 receptor. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine. Olopatadine is devoid of effects on alpha-adrenergic, dopamine and muscarinic type 1 and 2 receptors.

Signs and Symptoms · 1 Eintrag

Its side effects may include headaches (7% of occurrence) burning and stinging (5%), dry eye, foreign body sensation, hyperemia, keratitis, lid edema, pruritus, asthenia, cold syndrome, pharyngitis, rhinitis, sinusitis, and taste perversion. [Wikipedia]

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

Sicherheitsdaten

wgk
3
ridadr
UN 2811 6.1 / PGIII
hs_code
29329990
RTECS-Nr.
HQ4135060
risk_code
25-50
hazard_code
T,N
safety_code
45-61
Speicherklasse
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
Acute Tox. 3 OralAquatic Acute 1

Chemie und Industrie

Pharmakologische Informationen

Metabolism/MetabolitesThe mono-desmethyl and the N-oxide metabolites have been detected at low concentrations in the urine. Route of Elimination: Elimination was predominantly through renal excretion. Half Life: 3 hours
FDA Pharmacological Classification · 6 Einträge

OLOPATADINE HCL

Decreased Histamine Release [PE]; Mast Cell Stabilizer [EPC]; Histamine-1 Receptor Antagonist [EPC]; Histamine-1 Receptor Inhibitor [EPC]; Histamine H1 Receptor Antagonists [MoA]

OLOPATADINE HYDROCHLORIDE

Mast Cell Stabilizer [EPC]; Decreased Histamine Release [PE]; Histamine-1 Receptor Antagonist [EPC]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Inhibitor [EPC]

OLOPATADINE HYDROCHLORIDE OPHTHALMIC

Decreased Histamine Release [PE]; Mast Cell Stabilizer [EPC]; Histamine-1 Receptor Antagonist [EPC]; Histamine-1 Receptor Inhibitor [EPC]; Histamine H1 Receptor Antagonists [MoA]

MeSH Pharmacological Classification · 3 Einträge

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475)

A class of non-sedating drugs that bind to but do not activate histamine receptors (DRUG INVERSE AGONISM), thereby blocking the actions of histamine or histamine agonists. These antihistamines represent a heterogenous group of compounds with differing chemical structures, adverse effects, distribution, and metabolism. Compared to the early (first generation) antihistamines, these non-sedating antihistamines have greater receptor specificity, lower penetration of BLOOD-BRAIN BARRIER, and are less likely to cause drowsiness or psychomotor impairment.

Verwendung und Herstellung

UsesFor the treatment of ocular itching associated with allergic conjunctivitis. Used as an antihistamine. [Wikipedia]
Anwendungen · 2 Einträge

BeschreibungOlopatadine hydrochloride is an ophthalmic antihistamine that inhibits release of histamine from mast cells and is a relatively selective histamine H1 antagonist. It inhibits type 1 immediate hypersensitivity reactions. Olopatadine hydrochloride is indicated in the temporary relief of itching caused by allergic conjunctivitis. H1 antagonists have an established and valued place in the symptomatic treatment of various immediate hypersensitivity reactions. In addition, the central properties of some of the series are of therapeutic value for suppressing motion sickness or for sedation.

VerwendenOlopatadine hydrochloride is a potent, selective antagonist of the H1 histamine receptor (Ki = 16-41.1 nM), with much lower affinities for the H2 and H3 receptors (Ki = 43.4 and 172 μM, respectively). It blocks histamine-induced phosphoinositide turnover in isolated cells (IC50 = 9.5-39.9 nM) and prevents passive cutaneous anaphylaxis in rats (ED50 = 49 μg/kg) and anaphylactic bronchoconstriction in guinea pigs (ID50 = 30 μg/kg). Olopatadine is effective in treating allergic rhinitis and conjunctivitis. It also suppresses itch in patients with well-controlled chronic urticaria. In humans, this antihistamine does not cause cognitive or psychomotor impairment at therapeutic doses.[Cayman Chemical]

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

Olopatadine Ethyl Ester[3-(Dimethylamino)propyl]triphenylphosphonium bromide hydrobromide3-((Dimethylamino)propyl)triphenylphosphonium bromideOlopatadineIsoxepacUGDFSHGFPJSALM-OCKHKDLRSA-NChloro[3-(dimethylamino)propyl]magnesium3-Chlorpropyl(dimethyl)amin

Nachgelagerte Produkte

(E)-Olopatadine Hydrochloride

Zugehörige Reaktionen

2
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 422887
HRID 422887als Edukt
Reaktionsgleichung von HRID 2247135
HRID 2247135als Produkt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung